The Cigna Group (WBO:CIGN) Loans Receivable: €45 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:CIGN The Cigna Group WBO:CIGN
66 GF Score
Price €265.40
GF Value €369.78
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is The Cigna Group Loans Receivable?

The Cigna Group WBO:CIGN +4.08% 66 Loans Receivable is €45 Mil as of Mar. 2026. GuruFocus rates WBO:CIGN with a GF Score™ of 66/100 and a GF Value™ of €369.78 (Modestly Undervalued). The stock has 5 warning signs investors should review.

The Cigna Group's Loans Receivable for the quarter that ended in Mar. 2026 was €45 Mil.

The Cigna Group's quarterly Loans Receivable declined from Sep. 2025 (€85.20 Mil) to Dec. 2025 (€73.44 Mil) but then stayed the same from Dec. 2025 (€73.44 Mil) to Mar. 2026 (€44.98 Mil).

The Cigna Group's annual Loans Receivable declined from Dec. 2023 (€166.89 Mil) to Dec. 2024 (€0.00 Mil) but then increased from Dec. 2024 (€0.00 Mil) to Dec. 2025 (€73.44 Mil).

The Cigna Group Loans Receivable Related Terms

The Cigna Group Loans Receivable Historical Data

* Premium members only.

The historical data trend for The Cigna Group's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Cigna Group Loans Receivable Chart

The Cigna Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.80 63.25 166.89 0.00 73.44

The Cigna Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.05 91.04 85.20 73.44 44.98
WBO:CIGN
66GF Score
The Cigna Group WBO:CIGN
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Cigna Group Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of €45 Mil mean?
The Cigna Group (WBO:CIGN) has a Loans Receivable of €45 Mil as of Mar. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on The Cigna Group and its competitors.
Is The Cigna Group's Loans Receivable too high?
The Cigna Group's current Loans Receivable is €45 Mil. Overall, The Cigna Group has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Cigna Group's Loans Receivable compare to ELV and HUM?
The Cigna Group's Loans Receivable of €45 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Healthcare Plans company?
A good Loans Receivable depends on the Healthcare Plans industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on The Cigna Group and its competitors. The Cigna Group's current Loans Receivable is €45 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Cigna Group stock overvalued right now?
Based on GuruFocus' analysis, The Cigna Group (WBO:CIGN) is currently considered Modestly Undervalued. The stock's GF Value™ is €369.78, compared to a current price of €265.40 — trading 28.2% below its estimated fair value. The current Loans Receivable is €45 Mil. The Cigna Group's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For The Cigna Group (WBO:CIGN), the current Loans Receivable is €45 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Cigna Group (WBO:CIGN) Overvalued in 2026?

Based on GuruFocus' analysis, The Cigna Group stock appears to be undervalued. The current stock price of €265.40 is trading 28.2% below its estimated GF Value™ of €369.78. GuruFocus considers The Cigna Group to be Modestly Undervalued.

Key valuation signals for WBO:CIGN:

  • Loans Receivable: €45 Mil
  • GF Value™: €369.78 vs. price of €265.40 (28.2% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the WBO:CIGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Cigna Group Business Description

Address 900 Cottage Grove Road, Bloomfield, CT, USA, 06002
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
66GF Score

Get the complete analysis for WBO:CIGN

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€265.40
Price
€369.78
GF Value